210761-52-7Relevant academic research and scientific papers
Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy
Nottingham, Micheal,Bethel, Christopher R.,Pagadala, Sundar Ram Reddy,Harry, Emily,Pinto, Abishai,Lemons, Zachary A.,Drawz, Sarah M.,Akker, Focco Van Den,Carey, Paul R.,Bonomo, Robert A.,Buynak, John D.
scheme or table, p. 387 - 393 (2011/03/17)
In order to evaluate the importance of a hydrogen-bond donating substituent in the design of β-lactamase inhibitors, a series of C6-substituted penicillin sulfones, lacking a C2′ substituent, and having an sp 3 hybridized C6, was prepared and evaluated against a representative classes A and C β-lactamases. It was found that a C6 hydrogen-bond donor is necessary for good inhibitory activity, but that this feature alone is not sufficient in this series of C6β-substituted penicillin sulfones. Other factors which may impact the potency of the inhibitor include the steric bulk of the C6 substituent (e.g., methicillin sulfone) which may hinder recognition in the class A β-lactamases, and also high similarity to the natural substrates (e.g., penicillin G sulfone) which may render the prospective inhibitor a good substrate of both classes of enzyme. The best inhibitors had non-directional hydrogen-bonding substituents, such as hydroxymethyl, which may allow sufficient conformational flexibility of the acyl-enzyme for abstraction of the C6 proton by E166 (class A), thus promoting isomerization to the β-aminoacrylate as a stabilized acyl-enzyme.
Spirocyclopropyl β-lactams as mechanism-based inhibitors of serine β-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone
Sandanayaka, Vincent P.,Prashad, Amar S.,Yang, Youjun,Williamson, R. Thomas,Lin, Yang I.,Mansour, Tarek S.
, p. 2569 - 2571 (2007/10/03)
Class A-class C mechanism-based β-lactamase inhibitors were designed on the basis of the intermediacy of an oxycarbenium species capable of cross-linking with amino acids residues in the active site. Penams 24 and 27 were very potent against AmpC in vitro. The MIC values of 24 in combination with piperacillin against class A and class C producing organisms showed improvement over clinically used tazobactam.
